Phaies SRL
2.0 FTEThe score of Phaies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +214 % Total assets -9 % Headcount (avg FTE) -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phaies's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 61,462 € | ||||
| Equity | 159,987 € | ||||
| Cash | 39,469 € | ||||
| EBITDA | 114,928 € | ||||
| Total assets | 516,859 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Phaies's financial analysis
- Solvency31.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phaies
Phaies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0890.892.243
- VAT number
- BE0890892243
- Peppol
- Registered · 0208:0890892243 · as of 06 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jul 2007
- Registered office
- 6120 Ham-sur-Heure-Nalinnes
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phaies (SRL) has been based in Ham-sur-Heure-Nalinnes since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 61,462 € and equity of 159,987 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 31.0%, below the median of its sector (41.5%).
Companies similar to Phaies
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Van den Bergh Retail sale of pharmaceutical products Kontich · balance sheet 516,952 €
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
- Curepharma Retail sale of pharmaceutical products Antwerp · balance sheet 516,103 €
- Almapharma Retail sale of pharmaceutical products De Panne · balance sheet 515,565 €
- La Pharmacie de Saintes Retail sale of pharmaceutical products Tubize · balance sheet 514,575 €
- Milliemo Retail sale of pharmaceutical products Lochristi · balance sheet 519,776 €
- Pharmatheek Retail sale of pharmaceutical products Drogenbos · balance sheet 520,106 €
- Wezel Pharma Retail sale of pharmaceutical products Mol · balance sheet 520,638 €
Frequently asked questions about Phaies
What is the revenue of Phaies?
Phaies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phaies?
In Belgium, the VAT number is the company number prefixed with BE: BE0890892243 for Phaies, if the company is VAT-registered. Its company number (CBE) is 0890.892.243.
Where is the registered office of Phaies?
According to the CBE register, the registered office of Phaies is in 6120 Ham-sur-Heure-Nalinnes.
What is the equity of Phaies?
At the close of the 2025 financial year, the equity of Phaies amounts to 159,987 €, a solvency of 31.0% of total assets.
How many people work at Phaies?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phaies?
The register lists 1 active mandates at Phaies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phaies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →